Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Social Stream



Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): $0.79

0.01 (+0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CANF to Watchlist
Sign Up

Industry: Biotech


Ranked

of 409

in industry

CAN-FITE BIOPHARMA LTD (CANF) Price Targets From Analysts

Use the tables below to see what analysts covering CAN-FITE BIOPHARMA LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-09-13 2 $5 $5 $5 $0.789 533.71%

The Trend in the Analyst Price Target


Over the past 13 months, CANF's average price target has gone down $0.

CANF reports an average of 394.92% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-07 2 5 5 5 0.990 405.05%
2022-01-31 2 5 5 5 1.170 327.35%
2022-05-26 2 5 5 5 0.855 484.8%
2022-07-11 2 5 5 5 1.010 395.05%
2022-09-13 2 5 5 5 0.910 449.45%

CANF Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 35 weeks, CANF's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how CAN-FITE BIOPHARMA LTD fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
  • CAN-FITE BIOPHARMA LTD's number of analysts covering the stock is higher than 4.23% of Pharmaceutical Products stocks.
  • In the context of Healthcare stocks, CAN-FITE BIOPHARMA LTD's average analyst price target is greater than 6.69% of them.
  • In terms of how CAN-FITE BIOPHARMA LTD fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 78.84% of that group.

Stocks similar to CAN-FITE BIOPHARMA LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPTS, BNOX, and BLRX.

What is the outlook for CANF? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6193 seconds.